This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

September 21-24, 2020
Proudly part of BioPharm AmericaDelivered Digitally | US Eastern Daylight Time

Ralph Lipp, Ph.D.
President and CEO at Lipp Life Sciences LLC


Ralph Lipp, Ph.D. is President and CEO of Lipp Life Sciences LLC where his focuses on helping his clients elevate innovation and create value. Previously, as Chief Scientific Officer at Noven Pharmaceuticals he provided leadership to all research and development areas. At Schering where he started his industry career and later at Eli Lilly he headed various R&D functions with increasing responsibility for people and budget – up to 450 FTEs and up to $250 million. Ralph has been working in drug delivery for more than 25 years and his scientific contributions comprise more than 140 publications, including over 20 patents, covering five marketed medicines with aggregate peak annual sales exceeding $1 billion. Ralph holds a Ph.D. in Medicinal Chemistry and a Habilitation for Pharmaceutical Technology from Free University Berlin, Germany. He graduated from the International Executive Program, at INSEAD in Fontainebleau, France and from the Advanced Management Program, at Harvard Business School, Boston, MA, USA.

Ralph Lipp, Ph.D.'s Network

Agenda Sessions

  • Negotiation for Drug Delivery Innovation

  • Negotiation for Drug Delivery Innovation

  • Chairperson's Remarks